Literature DB >> 26768268

Circulating ANGPTL8/Betatrophin Concentrations Are Increased After Surgically Induced Weight Loss, but Not After Diet-Induced Weight Loss.

Eider Pascual-Corrales1, Javier Gómez-Ambrosi2,3,4, Rafael Moncada3,4,5, Víctor Valentí3,4,6, Victoria Catalán2,3,4, Amaia Rodríguez2,3,4, Beatriz Ramírez2,3,4, Camilo Silva1,3,4, María Jesús Gil3,4,7, Javier Salvador1,3,4, Gema Frühbeck8,9,10,11.   

Abstract

BACKGROUND: ANGPTL8/betatrophin is a secreted protein reported to be involved in β-cell replication that has recently been shown to be more related to lipid metabolism. Weight loss represents a clinical situation of improvement of glucose homeostasis and overall metabolic control. The aim of the present study was to analyze the impact of weight loss induced by either a conventional dietary treatment or bariatric surgery on ANGPTL8/betatrophin concentrations.
METHODS: Serum concentrations of ANGPTL8/betatrophin were measured by ELISA in 158 subjects before and 1 year after weight loss induced either by conventional dietary treatment (n = 38) or bariatric surgery (sleeve gastrectomy, n = 20, or Roux-en-Y gastric bypass, n = 100).
RESULTS: Massive surgery-induced weight loss after SG or RYGB was accompanied by a statistically significant increase in circulating levels of ANGPTL8/betatrophin (28.1 ± 13.9 to 40.3 ± 22.8 ng/mL, P = 0.001 after SG; 24.6 ± 10.9 to 41.7 ± 19.4 ng/mL, P < 0.001 after RYGB), while remaining unchanged 25.6 ± 13.3 to 25.4 ± 10.7 ng/mL (P = 0.891) after diet-induced weight loss. The change in ANGPTL8/betatrophin levels was positively correlated with the change in HDL-C concentrations.
CONCLUSIONS: Our study showed that serum ANGPTL8/betatrophin concentrations were increased in obese subjects after surgically induced weight loss, but not after weight loss achieved by conventional dietary treatment. The change in ANGPTL8/betatrophin concentrations emerged as a significant predictor of the change in HDL-C levels after weight loss.

Entities:  

Keywords:  ANGPTL8; Bariatric surgery; Betatrophin; Obesity; Weight loss

Mesh:

Substances:

Year:  2016        PMID: 26768268     DOI: 10.1007/s11695-015-2026-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  42 in total

1.  Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study.

Authors:  Bruno Geloneze; Sylka Rodovalho Geloneze; Elinton Chaim; Fernanda Filgueira Hirsch; Ana Claudia Felici; Giselle Lambert; Marcos Antonio Tambascia; José Carlos Pareja
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

2.  Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial.

Authors:  Evangelia Zvintzou; George Skroubis; Angelika Chroni; Peristera-Ioanna Petropoulou; Christina Gkolfinopoulou; George Sakellaropoulos; Donald Gantz; Ioanna Mihou; Fotios Kalfarentzos; Kyriakos E Kypreos
Journal:  J Clin Lipidol       Date:  2014-05-21       Impact factor: 4.766

3.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

4.  Betatrophin: a hormone that controls pancreatic β cell proliferation.

Authors:  Peng Yi; Ji-Sun Park; Douglas A Melton
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

5.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

6.  Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function.

Authors:  Lisa de las Fuentes; Alan D Waggoner; B Selma Mohammed; Richard I Stein; Bernard V Miller; Gary D Foster; Holly R Wyatt; Samuel Klein; Victor G Davila-Roman
Journal:  J Am Coll Cardiol       Date:  2009-12-15       Impact factor: 24.094

7.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

8.  Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes.

Authors:  Javier Gómez-Ambrosi; Eider Pascual; Victoria Catalán; Amaia Rodríguez; Beatriz Ramírez; Camilo Silva; María J Gil; Javier Salvador; Gema Frühbeck
Journal:  J Clin Endocrinol Metab       Date:  2014-07-22       Impact factor: 5.958

9.  Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.

Authors:  Xi Chen; Puhan Lu; Wentao He; Jianhua Zhang; Lei Liu; Yan Yang; Zhelong Liu; Junhui Xie; Shiying Shao; Tingting Du; Xianghui Su; Xinrong Zhou; Shuhong Hu; Gang Yuan; Muxun Zhang; Hong Zhang; Liegang Liu; Daowen Wang; Xuefeng Yu
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

10.  An EASO position statement on multidisciplinary obesity management in adults.

Authors:  Volkan Yumuk; Gema Frühbeck; Jean Michel Oppert; Euan Woodward; Hermann Toplak
Journal:  Obes Facts       Date:  2014-03-26       Impact factor: 3.942

View more
  10 in total

Review 1.  The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.

Authors:  Ren Zhang
Journal:  Open Biol       Date:  2016-04       Impact factor: 6.411

2.  Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.

Authors:  Dan Liu; Sheyu Li; He He; Chuan Yu; Xiaodan Li; Libo Liang; Yi Chen; Jianwei Li; Jianshu Li; Xin Sun; Haoming Tian; Zhenmei An
Journal:  Oncotarget       Date:  2017-03-14

3.  The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity.

Authors:  Mengdie Luo; Ziyu Zhang; Yani Peng; Shuai Wang; Daoquan Peng
Journal:  Cardiovasc Diabetol       Date:  2018-11-08       Impact factor: 9.951

4.  Cloning, expression, and spectral analysis of mouse betatrophin.

Authors:  Samaneh Gholami; Koroush Goodarzvand Chegini; Nematollah Gheibi; Kobra Mokhtarian; Mohsen Mohamadi; Reza Falak
Journal:  Med J Islam Repub Iran       Date:  2017-12-18

5.  Effect of Ileal Transposition (IT) on Angiopoietin-Like Protein-8 (ANGPTL8) and Pentraxin (PTX3) Plasma Level in Sprague-Dawley Rats Fed High-Fat Diet (HFD).

Authors:  Tomasz Sawczyn; Dominika Stygar; Katarzyna Nabrdalik; Michał Kukla; Oliwia Masri; Łukasz Magrowski; Wojciech Karcz; Jerzy Jochem
Journal:  Int J Endocrinol       Date:  2021-05-05       Impact factor: 3.257

6.  Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity.

Authors:  Carolina M Perdomo; Javier Gómez-Ambrosi; Sara Becerril; Víctor Valentí; Rafael Moncada; Eva M Fernández-Sáez; Leire Méndez-Giménez; Silvia Ezquerro; Victoria Catalán; Camilo Silva; Javier Escalada; Gema Frühbeck; Amaia Rodríguez
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

7.  A New Tactic for Label-Free Recognition of β-Trophin via Electrochemiluminescent Signalling on an AuNPs Supported Immuno-Interface.

Authors:  Lijuan Zheng; Chen Fang; Jilin Yan; Huiling Li; Yifeng Tu
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

Review 8.  ANGPTL8: An Important Regulator in Metabolic Disorders.

Authors:  Mengdie Luo; Daoquan Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-17       Impact factor: 5.555

9.  The circulating ANGPTL8 levels show differences among novel subgroups of adult patients with diabetes and are associated with mortality in the subsequent 5 years.

Authors:  Huajie Zou; Wu Duan; Zeqing Zhang; Xi Chen; Puhan Lu; Xuefeng Yu
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

10.  Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders.

Authors:  Jing Zheng; Juan Liu; Beverly S Hong; Weijian Ke; Minmin Huang; Yanbing Li
Journal:  BMC Endocr Disord       Date:  2020-04-16       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.